Table 2 Management, complications and outcome by type of degloving injury

Laboratory results

 Myoglobin

1190 ± 1179^b

1076 ± 1125

1636 ± 1293

0.02

 Blood Urea Nitrogen

4.8 ± 1.6^b

4.6 ± 1.4

5.5 ± 2

0.004

 Serum Creatinine

86.6 ± 37.3^b

81.6 ± 31

107 ± 52

0.01

 White blood cells

17.6 ± 7.7^b

18 ± 8

16 ± 7

0.09

 Platelets

250.8 ± 86.5^b

258 ± 86

224 ± 84

0.04

 Hemoglobin

12.9 ± 2.6^b

13 ± 2.5

12.6 ± 3

0.42

 INR

1.2 ± 0.3^b

1.19 ± 0.3

1.19 ± 0.2

0.92

 Serum Lactate

3.9 ± 2.4^b

4.05 ± 2.6

3.31 ± 1.9

0.72

Treatment of degloving Injury

 Packed RBC units

3 (1–25)^a

2 (1–20)

6 (1–25)

0.03

 Fresh Frozen Plasma units

6 (2–24)^a

5.5 (2–24)

6 (4–13)

0.46

 Platelets units

9 (1–28)^a

10 (1–28)

5 (1–11)

0.19

 Primary Debridement/suturing

112 (62.9 %)

105 (73.9 %)

7 (19.4 %)

0.001

 Initial conservative

28 (15.7 %)

0 (0.0 %)

28 (77.8 %)

0.001

 Serial debridement^b

34 (19.1 %)

33 (23.2 %)

1 (2.8 %)

0.003

 Late flap

22 (12.3 %)

21 (14.8 %)

1 (2.8 %)

0.05

Disposition

 Plastic surgery

26 (14.6 %)

23 (16.4 %)

3 (8.3 %)

0.22

 Rehabilitation

7 (3.9 %)

7 (4.9 %)

0 (0.0 %)

0.17

Hospital length of stay; days

10 (1–393)^a

11 (1–393)

6 (1–365)

0.11

Complications

 Skin Infection

7 (3.9 %)

6 (4.3 %)

1 (2.8 %)

0.68

 Skin necrosis

2 (1.1 %)

2 (1.4 %)

0 (0.0 %)

0.47

Mortality

16 (9.0 %)

9 (6.3 %)

7 (19.4 %)

0.01